Science Explorer Interactive view Map
Company · Marousi · Greece

Roche (Greece)

roche.grROR OpenAlex
Research works
33
▼ 61% vs 2013–17
Citations
466
14.0 per fractional work
Top-10% rate
42.8%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Roche (Greece) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.50× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.25× its world share, 0 worksImmunology and Micro…Environmental Science: 3.29× its world share, 1 worksEnvironmental ScienceHealth Professions: 0.57× its world share, 0 worksHealth ProfessionsMedicine: 2.60× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 8.82× its world share, 1 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.8×. Every wedge is a field page.

Which keywords describe research at Roche (Greece)?

By fractional works in all years, weighted toward what it does more of than the world: Immunogenicity, Monoclonal Antibodies, Bioanalytical Methods, Biosimilars, TGF-ß, Fibrosis, Idiopathic Pulmonary Fibrosis and Inflammation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Inflammation3▲ 4.0×13 topics
  2. Immunogenicity3▲ 150×2 topics
  3. Monoclonal Antibodies2▲ 52×2 topics
  4. Bioanalytical Methods2▲ 481×1 topic
  5. Biosimilars2▲ 481×1 topic
  6. TGF-ß2▲ 42×2 topics
  7. Fibrosis2▲ 36×1 topic
  8. Idiopathic Pulmonary Fibrosis2▲ 177×1 topic
  9. Cost of Care2▲ 325×1 topic
  10. Financial Toxicity2▲ 325×1 topic
  11. Epidemiology2▲ 1.34×9 topics
  12. European Legal Systems1▲ 90×1 topic
  13. Judicial Review1▲ 37×1 topic
  14. Metastasis1▲ 12×3 topics
  15. Quality of Life1▲ 2.9×3 topics
  16. Rituximab1▲ 24×2 topics
  17. Cancer Incidence1▲ 25×2 topics
  18. Autoantibodies1▲ 14×2 topics
  19. Breast Cancer1▲ 12×3 topics
  20. Cancer1▲ 2.3×8 topics
  21. Risk Assessment1▲ 5.6×2 topics
  22. Risk Factors1▲ 3.2×2 topics
  23. Comet Assay1▲ 68×1 topic
  24. Genotoxicity Testing1▲ 68×1 topic
  25. Global Surveillance1▲ 77×1 topic
  26. Lymphangiogenesis1▲ 191×1 topic
  27. Machine Learning1▲ 1.43×3 topics
  28. Management1▲ 3.9×5 topics
  29. Mortality Rates1▲ 32×1 topic
  30. VEGF-C1▲ 191×1 topic

Which research topics does Roche (Greece) publish most on?

By volume in 2022–2025: Economic and Financial Impacts of Cancer, Health, Environment, Cognitive Aging, Radiomics and Machine Learning in Medical Imaging and Medical Imaging Techniques and Applications.

Economic and Financial I…1Economic and Financial Impacts of Cancer: 1 fractional worksHealth, Environment, Cognitive Aging: 0 fractional worksRadiomics and Machine Learning in Medical Imaging: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksDiet and metabolism stud…0Diet and metabolism studies: 0 fractional worksGut microbiota and health: 0 fractional worksNutritional Studies and Diet: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksLipid metabolism and disorders: 0 fractional works
Economics and EconometricsHealth, Toxicology and MutagenesisRadiology, Nuclear Medicine and ImagingPhysiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  2. 2 Health, Environment, Cognitive Aging Health, Toxicology and Mutagenesis 0 works
  3. 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  6. 6 Diet and metabolism studies Physiology 0 works
  7. 7 Gut microbiota and health Molecular Biology 0 works
  8. 8 Nutritional Studies and Diet Public Health, Environmental and Occupational Health 0 works
  9. 9 Lipoproteins and Cardiovascular Health Surgery 0 works
  10. 10 Lipid metabolism and disorders Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.5%not open70.5%

World: 28% of research is openly available.

with international co-authors30.9%domestic only69.1%

World: 19% is written across borders.

How has Roche (Greece)'s research output changed?

Output in 2018–2022 was 61% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Marousi

All research institutions in Marousi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.